doi: 10.3969/j.issn.1674-9081.2018.02.007
More Information
  • Corresponding author: ZHAO Xiao-dong   Tel: 010-66867361.Email:xiaweibo8301@163.com
  • Received Date: 2018-01-09
  • Publish Date: 2018-03-30
  • loading
  • [1] 周学瀛, 夏维波.维生素D到底是什么?[J].中华骨质疏松和骨矿盐疾病杂志, 2015, 8:90-92. doi:  10.3969/j.issn.1674-2591.2015.01.017
    [2] Bikle D. Nonclassic actions of vitamin D[J]. J Clin Endocrinol Metab, 2009, 94:26-34. doi:  10.1210/jc.2008-1454
    [3] Holick MF. The Vitamin D solution: a 3-step strategy to cure our most common health problems[M]. New York:Plume, 2011.
    [4] Holick MF, Chen TC. Vitamin D deficiency: a worldwide problem with health consequences[J]. Am J Clin Nutr, 2008, 87:1080S-1086S. doi:  10.1093/ajcn/87.4.1080S
    [5] Chen J, Yun C, He Y, et al. Vitamin D status among the elderly Chinese population: a cross-sectional analysis of the 2010-2013 China National Nutrition and Health Survey (CNNHS) [J]. Nutr J, 2017, 16:3. doi:  10.1186/s12937-016-0224-3
    [6] Li M, Lv F, Zhang Z, et al. Establishment of a normal reference value of parathyroid hormone in a large healthy Chinese population and evaluation of its relation to bone turnover and bone mineral density[J]. Osteoporos Int, 2016, 27:1907-1916. doi:  10.1007/s00198-015-3475-5
    [7] Holick MF. Vitamin D deficiency[J]. N Engl J Med, 2007, 357:266-281. doi:  10.1056/NEJMra070553
    [8] Haddad JG, Matsuoka LY, Hollis BW, et al. Human plasma transport of vitamin D after its endogenous synthesis[J]. J Clin Invest, 1993, 91:2552-2555. doi:  10.1172/JCI116492
    [9] DeLuca HF. Overview of general physiologic features and functions of vitamin D[J]. Am J Clin Nutr, 2004, 80:1689S-1696S. doi:  10.1093/ajcn/80.6.1689S
    [10] Bikle DD, Gee E, Halloran B, et al. Assessment of the free fraction of 25-hydroxyvitamin D in serum and its regulation by albumin and the vitamin D-binding protein[J]. J Clin Endocrinol Metab, 1986, 63:954-959. doi:  10.1210/jcem-63-4-954
    [11] Christakos S, Dhawan P, Liu Y, et al. New insights into the mechanisms of vitamin D action[J]. J Cell Biochem, 2003, 88:695-705. doi:  10.1002/jcb.10423
    [12] Eisman JA, Bouillon R. Vitamin D: direct effects of vitamin D metabolites on bone: lessons from genetic-ally modified mice[J]. Bonekey Rep, 2014, 3:499.
    [13] Adams JS, Hewison M. Update in vitamin D[J]. J Clin Endocrinol Metab, 2010, 95:471-478. doi:  10.1210/jc.2009-1773
    [14] Liu PT, Stenger S, Li H, et al. Toll-like receptor triggering of a vitamin D-mediated human antimicrobial response[J]. Science, 2006, 311:1770-1773. doi:  10.1126/science.1123933
    [15] Bouillon R, Bischoff-Ferrari H, Willett W. Vitamin D and health: perspectives from mice and man[J]. J Bone Miner Res, 2008, 23:974-979. doi:  10.1359/jbmr.080420
    [16] Xie Z, Munson SJ, Huang N, et al. The mechanism of 1, 25-dihydroxyvitamin D(3) autoregulation in keratinocytes[J]. J Biol Chem, 2002, 277:36987-36990. doi:  10.1074/jbc.M201404200
    [17] Holick MF, Binkley NC, Bischoff-Ferrari HA, et al. Evaluation, treatment, and prevention of vitamin D deficiency: an endocrine society clinical practice guideline[J]. J Clin Endocrinol Metab, 2011, 96: 1911-1930. doi:  10.1210/jc.2011-0385
    [18] van Schoor N, Lips P. Global overview of vitamin D status[J]. Endocrinol Metab Clin North Am, 2017, 46:845-870. doi:  10.1016/j.ecl.2017.07.002
    [19] Hu Y, Chen J, Wang R, et al. Vitamin D nutritional status and its related factors for Chinese Children and Adolescents in 2010-2012[J].Nutrients, 2017, 9: 1024. doi:  10.3390/nu9091024
    [20] Ning Z, Song S, Miao L, et al. High prevalence of vitamin D deficiency in urban health checkup population[J]. Clin Nutr, 2016, 35:859-863. doi:  10.1016/j.clnu.2015.05.019
    [21] Man PW, van der Meer IM, Lips P, et al. Vitamin D status and bone mineral density in the Chinese population: a review[J]. Arch Osteoporos, 2016, 11:14. doi:  10.1007/s11657-016-0265-4
    [22] Lu H, Zhang Z, Ke Y, et al. High prevalence of vitamin D insufficiency in China: relationship with the levels of parathyroid hormone and markers of bone turnover[J]. PLoS One 2012, 7: e47264.
    [23] Zhen D, Liu L, Guan C, et al. High prevalence of vitamin D deficiency among middle-aged and elderly individuals in northwestern China: its relationship to osteoporosis and lifestyle factors[J]. Bone, 2015, 71:1-6. doi:  10.1016/j.bone.2014.09.024
    [24] Vieth R, Ladak Y, Walfish PG. Age-related changes in the 25-hydroxyvitamin D versus parathyroid hormone relationship suggest a different reason why older adults require more vitamin D[J]. J Clin Endocrinol Metab, 2003, 88:185-191. doi:  10.1210/jc.2002-021064
    [25] Touvier M, Deschasaux M, Montourcy M, et al. Determi-nants of vitamin D status in Caucasian adults: influ-ence of sun exposure, dietary intake, sociodemographic, lifestyle, anthropometric, and genetic factors[J]. J Invest Dermatol, 2015, 135:378-388. doi:  10.1038/jid.2014.400
    [26] Clemens TL, Adams JS, Henderson SL, et al.Increased skin pigment reduces the capacity of skin to synthesis vitamin D3[J]. Lancet, 1982, 1:74-76. doi:  10.1016/S0140-6736(82)90214-8
    [27] Grigalavicius M, Juzeniene A, Baturaite Z, et al. Biologi-cally efficient solar radiation: Vitamin D produc-tion and induction of cutaneous malignant melanoma[J]. Dermatoendo-crinology, 2013, 5:150-158. doi:  10.4161/derm.22941
    [28] Holick MF, Chen TC, Lu Z, et al.Vitamin D and skin physiology: a D-lightful story[J]. J Bone Miner Res, 2007, 22:28-33. doi:  10.1359/jbmr.07s211
    [29] Buyukuslu N, Esin K, Hizli H, et al.Clothing preference affects vitamin D status of young women[J]. Nutr Res, 2014, 34:688-693. doi:  10.1016/j.nutres.2014.07.012
    [30] Tsur A, Metzger M, Dresner-Pollak R. Effect of different dress style on vitamin D level in healthy young Orthodox and ultra-Orthodox students in Israel[J].Osteoporos Int, 2011, 22:2895-2898. doi:  10.1007/s00198-010-1492-y
    [31] Matsuoka LY, Ide L, Wortsman J, et al. Sunscreens supp-ress cutaneous vitamin D3 synthesis[J]. J Clin Endocrinol Metab, 1987, 64:1165-1168. doi:  10.1210/jcem-64-6-1165
    [32] Agarwal KS, Mughal MZ, Upadhyay P, et al. The impact of atmospheric pollution on vitamin D status of infants and toddlers in Delhi[J].India Arch Dis Child, 2002, 87:111-113. doi:  10.1136/adc.87.2.111
    [33] Chen J, Yun C, He Y, et al. Vitamin D status among the elderly Chinese population: a cross-sec-tional analysis of the 2010-2013 China national nutrition and health survey (CNNHS)[J]. Nutr J, 2017, 16:3. doi:  10.1186/s12937-016-0224-3
    [34] Manicourt DH, Devogelaer JP. Urban tropospheric ozone increases the prevalence of vitamin D deficiency among Belgian postmenopausal women with outdoor activities during summer[J]. J Clin Endocrinol Metab, 2008, 93:3893-3899. doi:  10.1210/jc.2007-2663
    [35] Feizabad E, Hossein-Nezhad A, Maghbooli Z, et al. Impact of air pollution on vitamin D deficiency and bone health in adolescents[J]. Arch Osteoporos. 2017, 12:34. http://www.wanfangdata.com.cn/details/detail.do?_type=perio&id=e651dcba08d709107fab4c2398d153e3
    [36] Hosseinpanah F, Pour SH, Heibatollahi M, et al.The effects of air pollution on vitamin D status in healthy women: a cross sectional study[J]. BMC Public Health, 2010, 10:519. doi:  10.1186/1471-2458-10-519
    [37] Kelishadi R, Moeini R, Poursafa P, et al. In-dependent association between air pollutants and vitamin D deficiency in young children in Isfahan, Iran[J]. Paediatr Int Child Health, 2014, 34:50-55. doi:  10.1179/2046905513Y.0000000080
    [38] Baïz N, Dargent-Molina P, Wark JD, et al. Gestational exposure to urban air pollution related to a decrease in cord blood vitamin d levels[J]. J Clin Endocrinol Metab, 2012, 97:4087-4095. doi:  10.1210/jc.2012-1943
    [39] Leary PF, Zamfirova I, Au J, et al. Effect of Latitude on Vitamin D Levels[J]. J Am Osteopath Assoc, 2017, 117:433-439. doi:  10.7556/jaoa.2017.089
    [40] Leung C, Warner J, Harris M, et al. Symptomatic Hypocalcemia Secondary to Rifampicin-induced Hypovitaminosis D[J]. Pediatr Infect Dis J, 2016, 35:822-823. doi:  10.1097/INF.0000000000001169
    [41] Hunter D, De Lange M, Snieder H, et al. Genetic contribution to bone metabolism, calcium excretion, and vitamin D and parathyroid hormone regulation[J]. J Bone Miner Res, 2001, 16:371-378. doi:  10.1359/jbmr.2001.16.2.371
    [42] Shea MK, Benjamin EJ, Dupuis J, et al. Genetic and non-genetic correlates of vitamins K and D[J]. Eur J Clin Nutr, 2009, 63:458-464. doi:  10.1038/sj.ejcn.1602959
    [43] Wjst M, Altmüller J, Braig C, et al. A genome-wide linkage scan for 25-OH-D(3) and 1, 25-(OH)2-D3 serum levels in asthma families[J]. J Steroid Biochem Mol Biol, 2007, 103:799-802. doi:  10.1016/j.jsbmb.2006.12.053
    [44] Wang TJ, Zhang F, Richards JB, et al. Common genetic determinants of vitamin D insufficiency: a genome-wide association study[J]. Lancet, 2010, 376:180-188. doi:  10.1016/S0140-6736(10)60588-0
    [45] Nissen J, Vogel U, Ravn-Haren G, et al.Common variants in CYP2R1 and GC genes are both determinants of serum 25-hydroxyvitamin D concentrations after UVB irradiation and after consumption of vitamin D3-fortified bread and milk during winter in Denmark[J]. Am J Clin Nutr, 2015, 101:218-227. doi:  10.3945/ajcn.114.092148
    [46] Ordóñz-Mena JM, Maalmi H, Schöttker B, et al. Genetic variants in the vitamin D pathway, 25(OH)D Levels, and mortality in a large population-based cohort study[J]. J Clin Endocrinol Metab, 2017, 102:470-477. doi:  10.1210/jc.2016-2468
    [47] Zhang Z, He JW, Fu WZ, et al. An analysis of the association between the vitamin D pathway and serum 25-hydroxyvitamin D levels in a healthy Chinese population[J]. J Bone Miner Res, 2013, 28:1784-1792. doi:  10.1002/jbmr.1926
    [48] Li SS, Gao LH, Zhang XY, et al. Genetically low vitamin d levels, bone mineral density, and bone metabolism markers: a Mendelian Randomisation study[J]. Sci Rep, 2016, 6:33202. doi:  10.1038/srep33202
    [49] Thacher TD, Fischer PR, Pettifor JM. Rickets: vitamin D and calcium deficiency[J]. J Bone Miner Res, 2007, 22:638. doi:  10.1359/jbmr.070118
    [50] Shaw NJ, Mughal MZ. Vitamin D and child health Part 1 (skeletal aspects)[J]. Arch Dis Child, 2013, 98:363-367. doi:  10.1136/archdischild-2011-301264
    [51] 孟迅吾.骨软化症和佝偻病[M]//史轶蘩.协和内分泌代谢学.北京: 科学出版社, 1999: 1529-1542.
    [52] Lieben L, Masuyama R, Torrekens S, et al. Normocalcemia is maintained in mice under conditions of calcium malabsorption by vitamin D-induced inhibition of bone mineralization[J]. J Clin Invest, 2012, 122:1803-1815. doi:  10.1172/JCI45890
    [53] Tiosano D, Hochberg Z. Hypophosphatemia: the common denominator of all rickets[J]. J Bone Miner Metab, 2009, 27:392-401. doi:  10.1007/s00774-009-0079-1
    [54] Kim CJ, Kaplan LE, Perwad F, et al. Vitamin D 1alphahy-droxylase gene mutations in patients with 1alpha-hydroxylase deficiency[J]. J Clin Endocrinol Metab, 2007, 92:3177-3182. doi:  10.1210/jc.2006-2664
    [55] Cui N, Xia W, Su H, et al. Novel mutations of CYP27B1 gene lead to reduced activity of 1α-hydroxylase in Chinese patients[J]. Bone, 2012, 51:563-569. doi:  10.1016/j.bone.2012.05.006
    [56] Thacher TD, Fischer PR, Singh RJ, et al. CYP2R1 Mutations Impair Generation of 25-hydroxyvitamin D and Cause an Atypical Form of Vitamin D Deficiency[J]. J Clin Endocrinol Metab, 2015, 100:E1005-E1013. http://www.wanfangdata.com.cn/details/detail.do?_type=perio&id=f9399b7086904ee5718b6a63ca0745c8
    [57] Pang Q, Qi X, Jiang Y, et al. Clinical and genetic findings in a Chinese family with VDR-associated hereditary vitamin D-resistant rickets[J]. Bone Res, 2016, 4:16018. doi:  10.1038/boneres.2016.18
    [58] Huang XL, Jiang Y, Xia WB. FGF23 and Phosphate Wasting Disorders[J]. Bone Res, 2013, 2: 120-132. doi:  10.4248/BR201302002
    [59] Jiang Y, Xia WB, Xing XP, et al. Tumor-induced osteomalacia: an important cause of adult-onset hypophosphatemic osteomalacia in China: Report of 39 cases and review of the literature[J]. J Bone Miner Res, 2012, 27: 1967-1975. doi:  10.1002/jbmr.1642
    [60] 中华医学会骨质疏松和骨矿盐疾病分会.原发性骨质疏松症诊疗指南[J].中华骨质疏松和骨矿盐疾病杂志, 2017, 10:413-444. doi:  10.3969/j.issn.1674-2591.2017.05.002
    [61] WHO. Facts about ageing[EB/OL].[2018-02-04].http://www.who.int/ageing/about/facts/en/indexhtml.
    [62] Chen W, Simpson JM, March LM, et al. Co-morbidities only account for a small proportion of excess mortality after fracture: a record linkage study of individual fracture types[J]. J Bone Miner Res, 2018. doi: 10.1002/jbmr.3374. [Epub ahead of print].
    [63] Cruz-Jentoft AJ, Baeyens JP, Bauer JM, et al. Sarcopenia: European consensus on definition and diagnosis: Report of the European Working Group on sarcopenia in older people[J]. Age Ageing, 2010, 39:412-423. doi:  10.1093/ageing/afq034
    [64] Haussler MR, Whitfield GK, Kaneko I, et al. Molecular mechanisms of vitamin D action[J].Calcif Tissue Int, 2013, 92:77-98. doi:  10.1007/s00223-012-9619-0
    [65] Olsson K, Saini A, Strömberg A, et al. Evidence for vitamin D receptor expression and direct effects of 1α, 25(OH)2D3 in human skeletal muscle precursor cells[J]. Endocrinology, 2016, 157:98-111. doi:  10.1210/en.2015-1685
    [66] Kotlarczyk MP, Perera S, Ferchak MA, et al. Vitamin Ddeficiencyis associated with functional decline and falls in frail elderly women despite supplementation[J]. Osteoporos Int, 2017, 28:1347-1353. doi:  10.1007/s00198-016-3877-z
    [67] Weaver CM, Gordon CM, Janz KF, et al. The National Osteoporosis Foundation's position statement on peak bone mass development and lifestyle factors: a systematic review and implementation recommendations[J].Osteoporos Int, 2016, 27:1281-1386. doi:  10.1007/s00198-015-3440-3
    [68] Seamans KM, Hill TR, Scully L, et al. Vitamin d status and indices of bone turnover in older European adults[J].Int J Vitam Nutr Res, 2011, 81:277-285. doi:  10.1024/0300-9831/a000075
    [69] Kruger MC, Kruger IM, Wentzel-Viljoen E, et al. Urbanization of black South African women may increase risk of low bone mass due to low vitamin D status, low calcium intake, and high bone turnover[J].Nutr Res, 2011, 31:748-758. doi:  10.1016/j.nutres.2011.09.012
    [70] Ebeling PR. Vitamin D and bone health: epidemiologic studies[J]. Bonekey Rep, 2014, 3:511. http://europepmc.org/articles/pmc4015454/
    [71] Reid IR, Bolland MJ, Grey A. Effects of vitamin D supplements on bone mineral density: a systematic review and meta-analysis[J]. Lancet, 2014, 11, 383:146-155. doi:  10.1016/S0140-6736(13)61647-5
    [72] Dawson-Hughes B, Mithal A, Bonjour JP, et al. IOF position statement: vitamin D recommendations for older adults[J]. Osteoporos Int, 2010, 21:1151-1154. doi:  10.1007/s00198-010-1285-3
    [73] Bischoff-Ferrari HA, Dawson-Hughes B, Willett WC, et al. Effect of Vitamin D on falls: a meta-analysis[J]. JAMA, 2004, 291:1999-2006. doi:  10.1001/jama.291.16.1999
    [74] Bischoff-Ferrari HA, Dawson-Hughes B, Staehelin HB, et al. Fall prevention with supplemental and active forms of vitamin D: a meta-analysis of rando-mised controlled trials[J]. BMJ, 2009, 339:b3692. doi:  10.1136/bmj.b3692
    [75] Chung M, Lee J, Terasawa T, et al. Vitamin D with or without calcium supplementation for prevention of cancer and fractures: an updated meta-analysis for the U.S. Preventive Services Task Force[J]. Ann Intern Med, 2011, 155:827-838. doi:  10.7326/0003-4819-155-12-201112200-00005
    [76] Bischoff-Ferrari HA, Orav EJ, Dawson-Hughes B. Effect of cholecalciferol plus calcium on falling in ambulatory older men and women: a 3-year randomized controlled trial[J]. Arch Intern Med, 2006, 166:424-430. doi:  10.1001/archinte.166.4.424
    [77] O'Donnell S, Moher D, Thomas K, et al. Systematic review of the benefits and harms of calcitriol and alfacalcidol for fractures and falls[J].J Bone Miner Metab, 2008, 26:531-542. doi:  10.1007/s00774-008-0868-y
    [78] Liao RX, Yu M, Jiang Y, et al. Management of osteoporo-sis with calcitriol in elderly Chinese patients: a systematic review[J].Clin Interv Aging, 2014, 28, 9:515-526. doi:  10.2147/CIA.S40465
    [79] Zhang ZL, Liao EY, Xia WB, et al. Alendronate sodium/vitamin D3 combination tablet versus calcitriol for osteoporosis in Chinesepostmenopausal women: a 6-month, randomized, open-label, active-comparator-controlled study with a 6-month extension[J].Osteoporos Int, 2015, 26: 2365-2374. doi:  10.1007/s00198-015-3141-y
    [80] Pittas AG, Sun Q, Manson JE, et al. Plasma 25-hydroxyvitamin D concentration and risk of incident type 2 diabetes in women[J]. Diabetes Care, 2010, 33:2021-2023. doi:  10.2337/dc10-0790
    [81] Forouhi NG, Ye Z, Rickard AP, et al. Circulating 25-hydroxyvitamin D concentration and the risk of type 2 diabetes: results from the European Prospective Investigation into Cancer (EPIC)-Norfolk cohort and updated meta-analysis of prospective studies[J]. Diabetologia, 2012, 55:2173-2182. doi:  10.1007/s00125-012-2544-y
    [82] Takiishi T, Gysemans C, Bouillon R, et al. Vitamin D and diabetes[J]. Rheum Dis Clin North Am, 2012, 38:179-206. doi:  10.1016/j.rdc.2012.03.015
    [83] Palomer X, Gonzalez-Clemente JM, Blanco-Vaca F, et al. Role of vitamin D in the pathogenesis of type 2 diabetes mellitus[J]. Diabetes Obes Metab, 2008, 10:185-197. doi:  10.1111/j.1463-1326.2007.00710.x
    [84] Flores M. A role of vitamin D in low-intensity chronic inflammation and insulin resistance in type 2 diabetes mellitus? [J]. Nutr Res Rev, 2005, 18:175-182. doi:  10.1079/NRR2005104
    [85] Martini LA, Wood RJ. Vitamin D status and the metabolic syndrome[J]. Nutr Rev, 2006, 64:479-486. doi:  10.1111/j.1753-4887.2006.tb00180.x
    [86] Mirhosseini N, Vatanparast H, Mazidi M, et al. The effect of improved serum 25-hydroxyvitamin D status on glycemic control in diabetic patients: A meta-analysis[J]. J Clin Endocrinol Metab, 2017, 102:3097-3110. doi:  10.1210/jc.2017-01024
    [87] Gagnon C, Lu ZX, Magliano DJ, et al. Serum 25-hydroxyvitamin D, calcium intake, and risk of type 2 diabetes after 5 years: results from a national, population-based prospective study (the Australian Diabetes, Obesity and Lifestyle study) [J]. Diabetes Care, 2011, 34:1133-1138. doi:  10.2337/dc10-2167
    [88] Mitri J, Muraru MD, Pittas AG. Vitamin D and type 2 diabetes: a systematic review[J]. Eur J Clin Nutr, 2011, 65:1005-1015. doi:  10.1038/ejcn.2011.118
    [89] Luo BA, Gao F, Qin LL. The association between Vitamin D deficiency and diabetic retinopathy in type 2 diabetes: A meta-analysis of observational studies[J]. Nutrients, 2017, 20 : 307. doi:  10.3390/nu9030307
    [90] de Boer IH, Tinker LF, Connelly S, et al. Women's Health Initiative Investigators. Calcium plus vitamin D supplementa-tion and the risk of incident diabetes in the Women's Health Initiative[J]. Diabetes Care, 2008, 31:701-707. doi:  10.2337/dc07-1829
    [91] Davidson MB, Duran P, Lee ML, et al. High-dose vitamin D supplementation in people with prediabetes and hypovitaminosis D[J]. Diabetes Care, 2013, 36:260-266. doi:  10.2337/dc12-1204
    [92] Jorde R, Sollid ST, Svartberg J, et al. Vitamin D 20, 000 IU per week for five years does not prevent progression from prediabetes to diabetes[J]. J Clin Endocrinol Metab, 2016, 101:1647-1655. doi:  10.1210/jc.2015-4013
    [93] Zostautiene I, Jorde R, Schirmer H, et al. Genetic variations in the vitamin D receptor predict type 2 diabetes and myocardial infarction in a community-based population: The Troms Study[J]. PLoS One, 2015, 10:e0145359. doi:  10.1371/journal.pone.0145359
    [94] Li L, Wu B, Liu JY, et al. Vitamin D receptor gene polymorphisms and type 2 diabetes: a meta-analysis[J]. Archives Med Res, 2013, 44:235-241. doi:  10.1016/j.arcmed.2013.02.002
    [95] Pilz S, Kienreich K, Rutters F, et al. Role of vitamin D in the development of insulin resistance and type 2 diabetes[J]. Curr Diab Rep, 2013, 13:261-270. doi:  10.1007/s11892-012-0358-4
    [96] Norman AW. Minireview: vitamin D receptor: new assignments for an already busy receptor[J]. Endocrinology, 2006, 147:5542-5548. doi:  10.1210/en.2006-0946
    [97] Maestro B, Campion J, Dávila N, et al. Stimulation by 1, 25-dihydroxyvitamin D3 of insulin receptor expression and insulin responsiveness for glucose transport in U-937 human promonocytic cells[J]. Endocr J, 2000, 47:383-391. doi:  10.1507/endocrj.47.383
    [98] Pittas AG, Lau J, Hu FB, Dawson-Hughes B. The role of vitamin D and calcium in type 2 diabetes.A systematic review and meta-analysis[J]. J Clin Endocrinol Metab, 2007, 92:2017-2029. doi:  10.1210/jc.2007-0298
    [99] Sisley SR, Arble DM, Chambers AP, et al. Hypothalamic vitamin D improves glucose homeostasis and reduces weight[J]. Diabetes, 2016, 65:2732-2741. doi:  10.2337/db16-0309
    [100] Chen S, Glenn DJ, Ni W, et al. Expression of the vitamin D receptor is increased in the hypertrophic heart [J]. Hypertension, 2008, 52: 1106-1112. doi:  10.1161/HYPERTENSIONAHA.108.119602
    [101] Zanetti M, Harris SS, Dawson-Hughes B. Ability of vitamin D to reduce inflammation in adults without acute illness [J]. Nutr Rev, 2014, 72: 95-98. doi:  10.1111/nure.12095
    [102] Hansen D, Rasmussen K, Rasmussen LM, et al. The influence of vitamin D analogs on calcification modulators, N-terminal pro-B-type natriuretic peptide and inflammatory markers in hemodialysis patients: a randomized crossover study [J]. BMC Nephrol, 2014, 15: 130. doi:  10.1186/1471-2369-15-130
    [103] Norman PE, Powell JT. Vitamin D and cardiova-scular disease [J]. Circ Res, 2014, 114: 379-393. doi:  10.1161/CIRCRESAHA.113.301241
    [104] Adami S, Viapiana O, Gatti D, et al.Relationship between serum parathyroid hormone, vitamin D sufficiency, age, and calcium intake [J]. Bone, 2008, 42: 267-270. doi:  10.1016/j.bone.2007.10.003
    [105] Cho HJ, Kang HC, Choi SA, et al.The possible role of Ca2+ on the activation of microsomal triglyceride transfer protein in rat hepatocytes [J]. Bio Pharm Bull, 2005, 28: 1418-1423. doi:  10.1248/bpb.28.1418
    [106] Giovinazzo S, Alibrandi A, Campenni A, et al. Correlation of cardio-metabolic parameters with vitamin D status in healthy premenopausal women [J]. J Endocrinol Invest, 2017, 40:1337-1343. doi:  10.1007/s40618-017-0707-x
    [107] Hao Y, Ma X, Luo Y, et al. Additional role of serum 25-hydroxyvitamin D3 levels in atherosclerosis in Chinese middle-aged and elderly men[J]. Clin Exp Pharmacol Physiol, 2014, 41: 174-179. doi:  10.1111/1440-1681.12200
    [108] Milazzo V, Metrio MD, Cosentino N, et al. Vitamin D and acute myocardial infarction [J]. World J Cardiol, 2017, 9: 14-20. doi:  10.4330/wjc.v9.i1.14
    [109] Gotsman I, Shauer A, Zwas DR, et al. Vitamin D deficiency is a predictor of reduced survival in patients with heart failure, vitamin D supplementation improves outcome [J]. Eur J Heart Fail, 2012, 14: 357-366. doi:  10.1093/eurjhf/hfr175
    [110] Afshari L, Amani R, Soltani F, et al. The relation between serum Vitamin D levels and body antioxidant status in ischemic stroke patients: a case-control study [J]. Adv Biomed Res, 2015, 4: 213.
    [111] Anderson JL, May HT, Horne BD, et al. Relation of vitamin D deficiency to cardiovascular risk factors, disease status, and incident events in a general healthcare popula-tion [J]. Am J Cardiol, 2010, 106: 963-968. doi:  10.1016/j.amjcard.2010.05.027
    [112] Pérez-Hernández N, Aptilon-Duque G, Nostroza-Hernández MC, et al. Vitamin D and its effects on cardiovascular diseases: a comprehensive review [J]. Korean J Intern Med, 2016, 31: 1018-1029. doi:  10.3904/kjim.2015.224
    [113] Schleithoff SS, Zittermann A, Tenderich G, et al. Vitamin D supplementation improves cytokine profiles in patients with congestive heart failure: a double-blind, randomized, placebo-controlled trial [J]. Am J Clin Nutr, 2006, 83: 754-759. doi:  10.1093/ajcn/83.4.754
    [114] Endo I, Inoue D, Mitsui T, et al. Deletion of vitamin D receptor gene in mice results in abnormal skeletal muscle development with deregulated expres-sion of myoregulatory transcription factors [J]. Endocrinology, 2003, 144: 5138-5144. doi:  10.1210/en.2003-0502
    [115] Srikuea R, Zhang X, Park-Sarge OK, et al. VDR and CYP27B1 are expressed in C2C12 cells and regenerating skeletal muscle: potential role in suppression of myoblast proliferation [J]. Am J Physiol Cell Physiol, 2012, 303: C396-C405. doi:  10.1152/ajpcell.00014.2012
    [116] Ryan ZC, Craig TA, Folmes CD, et al. 1Alpha, 25-Dihydroxyvitamin D3 regulates mitochondrial oxygen consump-tion and dynamics in human skeletal muscle cells[J]. J Biol Chem, 2016, 291: 1514-1528. doi:  10.1074/jbc.M115.684399
    [117] 曾琴, 谢忠建.维生素D与骨骼肌[J].中华骨质疏松和骨矿盐疾病杂志, 2016, 9: 103-109. doi:  10.3969/j.issn.1674-2591.2016.02.001
    [118] Wang Y, DeLuca HF. Is the vitamin D receptor found in muscle? [J]. Endocrinology, 2011, 152:354-363. doi:  10.1210/en.2010-1109
    [119] Priemel M, von Domarus C, Klatte TO, et al. Bone mineralization defects and vitamin D deficiency: histomorpho-metric analysis of iliac crest bone biopsies and circulating 25-hydroxyvitamin D in 675 patients[J]. J Bone Miner Res, 2010, 25: 305-312. doi:  10.1359/jbmr.090728
    [120] Rosen CJ, Adams JS, Bikle DD, et al. The Nonskeletal Effects of Vitamin D: An Endocrine Society Scientific Statement[J]. Endocrine Rev, 2012, 33: 456-492. doi:  10.1210/er.2012-1000
    [121] Visser M, Deeg DJ, Lips P, et al. Low vitamin D and high parathyroid hormone levels as determinants of loss of muscle strength and muscle mass (sarcopenia): the Longitudinal Aging Study Amsterdam[J]. J Clin Endocrinol Metab, 2003, 88: 5766-5772. doi:  10.1210/jc.2003-030604
    [122] Murad MH, Elamin KB, Abu Elnour NO, et al. The effect of vitamin D on falls.A systematic review and meta-analysis[J]. J Clin Endocrinol Metab, 2011, 96: 2997-3006. doi:  10.1210/jc.2011-1193
    [123] Mathieu C, Waer M, Laureys J, et al. Prevention of autoimmune diabetes in NOD mice by 1, 25 dihydroxyvitamin D3[J]. Diabetologia, 1994, 37:552-558. doi:  10.1007/BF00403372
    [124] Koduah P, Paul F, Dör JM. Vitamin D in the prevention, prediction and treatment of neurodegenerative and neuroinflammatory diseases[J]. EPMA J, 2017, 8:313-325. doi:  10.1007/s13167-017-0120-8
    [125] Rolf L, Muris AH, Hupperts R, et al. Illuminating vitamin D effects on B-cells-the multiple sclerosis perspective[J]. Immunology, 2016, 147:275-284. doi:  10.1111/imm.12572
    [126] Hyppönen E, Läärä E, Reunanen A, et al. Intake of vitamin D and risk of type 1 diabetes: a birth-cohort study[J]. Lancet, 2001, 358:1500-1503. doi:  10.1016/S0140-6736(01)06580-1
    [127] Sakthiswary R, Raymond AA. The clinical signifi-cance of vitamin D in systemic lupus erythematosus: a systematic review[J].PLoS One, 2013, 8:e55275. doi:  10.1371/journal.pone.0055275
    [128] Meeker S, Seamons A, Maggio-Price L, et al. Protective links between vitamin D, infiammatory bowel disease and colon cancer[J].World J Gastro-enterol, 2016, 22: 933-948. doi:  10.3748/wjg.v22.i3.933
    [129] Dou R, Ng K, Giovannucci EL, et al. Vitamin D and Colorectal Cancer: Molecular, Epidemiological, and Clinical Evidence[J].Br J Nutr, 2016, 115: 1643-1660.
    [130] Song M, Nishihara R, Wang M, et al. Plasma 25-hydroxyvitamin D and colorectal cancer risk according to tumour immunity status[J].Gut, 2016, 65: 296-304. doi:  10.1136/gutjnl-2014-308852
    [131] Holick MF. High prevalence of vitamin D inadequacy and implications for health[J]. Mayo Clin Proc, 2006, 81:353-373. doi:  10.4065/81.3.353
    [132] Moan J, Porojnicu AC, Dahlback A, et al. Addressing the health benefits and risks, involving vitaminDor skin cancer, of increased sun exposure[J]. Proc Natl Acad Sci USA, 2008, 105:668-673. doi:  10.1073/pnas.0710615105
    [133] Holick MF, Biancuzzo RM, Chen TC, et al. Vitamin D2 is as effective as vitaminD3 in maintaining circulating concentrations of 25-hydroxyvitamin D[J]. J Clin Endocrinol Metab, 2008, 93:677-681. doi:  10.1210/jc.2007-2308
    [134] Holick MF. Sunlight "D" ilemma: risk of skin cancer or bone disease and muscle weakness[J]. Lancet, 2001, 357:4-6. doi:  10.1016/S0140-6736(00)03560-1
    [135] Carpenter TO, Imel EA, Holm IA, et al. A clinician's guide to X-linked hypophosphatemia[J]. J Bone Miner Res, 2011, 26: doi:  10.1002/jbmr.2440
    [136] 史轶蘩.协和内分泌代谢学[M].北京:科学出版社, 1999:1478-1486.
    [137] Bollerslev J, Rejnmark L, Marcocci C, et al. European society of endocrinology clinical guideline: treatment of chronic hypoparathyroidism in adults[J]. Eur J Endocrinol, 2015, 173:1-20. doi:  10.1530/EJE-14-0815
    [138] Brandi ML, Bilezikian JP, Shoback D, et al. Management of hypoparathyroidism: summary statement and guidelines[J]. J Clin Endocrinol Metab, 2016, 101: 2273-2283. doi:  10.1210/jc.2015-3907
    [139] Sikjaer T, Rejnmark L, Thomsen JS, et al. Changes in 3-dimensional bone structure indices in hypoparathyroid patients treated with PTH(1-84): a randomized controlled study[J]. J Bone Miner Res, 2012, 27:781-788. doi:  10.1002/jbmr.1493
    [140] Kruger MC, Chan YM, Lau LT, et al. Calcium and vitamin D fortified milk reduces bone turnover and improves bone density in postmenopausal women over 1 year[J]. Eur J Nutr, 2017. doi:  10.1007/s00394-017-1544-6.[Epub ahead of print].
    [141] Laiz A, Malouf J, Marin A, et al. Impact of 3-monthly vitamin D supplementation plus exercise on survival after surgery for osteoporotic hip fracture in adult patients over 50 years: a pragmatic randomi-zed, partially blinded, controlled trial[J]. J Nutr Health Aging, 2017, 21:413-420. doi:  10.1007/s12603-016-0773-3
    [142] IOM.IOM dietary reference ranges for calcium and vitamin D[EB/OL].(2012-02-13). http://www. iom.edu/ Reports/2010/DietaryReference-Intakes-for-Calcium-and-Vitamin-D.aspx.
    [143] Sanders KM, Stuart AL, Williamson EJ, et al.Annual high-dose oral vitamin D and falls and fractures in older women. A randomized controlled trial[J]. JAMA, 2010, 303:1815-1822. doi:  10.1001/jama.2010.594
    [144] ] Bleicher K, Cumming RG, Naganathan V, et al. U-shaped association between serum 25-hydroxyvitamin D and fracture risk in older men: results from the prospective population-based CHAMP study[J]. J Bone Miner Res, 2014, 29:2024-2031. doi:  10.1002/jbmr.2230
    [145] Cianferotti L, Cricelli C, Kanis JA, et al.The clinical use of vitamin D metabolites and their potential developments: a position statement from the European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO) and the Intern-ational Osteoporosis Foundation (IOF)[J]. Endocrine, 2015, 50:12-26. doi:  10.1007/s12020-015-0606-x
    [146] Matsumoto T, Ito M, Hayashi Y, et al. A new active vitamin D3 analog, eldecalcitol, prevents the risk of osteopo-rotic fractures-a randomized, active comparator, double-blind study[J]. Bone, 2011, 49:605-612. doi:  10.1016/j.bone.2011.07.011
    [147] Hagino H, Takano T, Fukunaga M, et al. Eldecalcitol reduces the risk of severe vertebral fractures and improves the health-related quality of life in patients with osteoporosis[J]. J Bone Miner Metab, 2013, 31:183-189. doi:  10.1007/s00774-012-0397-6
    [148] EVOLVE Trial Investigators, Chertow GM, Block GA, et al. Effect of cinacalcet on cardiovascular disease in patients undergoing dialysis[J]. N Engl J Med, 2012, 367: 2482-2494. doi:  10.1056/NEJMoa1205624
    [149] Kidney disease: improving global outcomes (KDIGO) CKD-MBD update work group. KDIGO 2017 clinical practice guideline update for the diagnosis, evalua-tion, prevention, and treatment of chronic kidney disease-mineral and bone disorder (CKD-MBD)[J]. Kidney Int Suppl, 2017, 7: 1-59. doi:  10.1016/j.kisu.2017.04.001
    [150] Thadhani R, Appelbaum E, Pritchett Y, et al. Vitamin D therapy and cardiac structure and function in patients with chronic kidney disease: the PRIMO randomized controlled trial[J]. JAMA, 2012, 307: 674-684. doi:  10.1001/jama.2012.120
    [151] Li XH, Feng L, Yang ZH, et al. The effect of active vitamin d on cardiovascular outcomes in predialysis chronic kidney diseases: a systematic review and meta-analysis[J]. Nephrology (Carlton), 2015, 20: 706-714. doi:  10.1111/nep.12505
    [152] Iimori S, Mori Y, Akita W, et al. Diagnostic usefulness of bone mineral density and biochemical markers of bone turnover in predicting fracture in CKD stage 5D patients—a single-center cohort study[J]. Nephrol Dial Transplant, 2012, 27: 345-351. doi:  10.1093/ndt/gfr317
    [153] West SL, Lok CE, Langsetmo L, et al. Bone mineral density predicts fractures in chronic kidney disease[J]. J Bone Miner Res, 2015, 30: 913-919. doi:  10.1002/jbmr.2406
    [154] Bleiker TO, Bourke JF, Mumford R, et al. Long-term outcome of severe chronic plaque psoriasis following treatment with high-dose topical calcipotriol[J]. Br J Dermatol, 1998, 139:285-286. doi:  10.1046/j.1365-2133.1998.02367.x
    [155] Hardman KA, Heath DA, Nelson HM. Hypercalcaemia associated with calcipotriol (Dovonex) treatment[J]. BMJ, 1993, 306:896-896. http://www.wanfangdata.com.cn/details/detail.do?_type=perio&id=HighWire000005553481
    [156] Russell S, Young MJ. Hypercalcaemia during treatment of psoriasis with calcipotripl[J]. Br J Dermatol, 1994, 130:795. doi:  10.1111/j.1365-2133.1994.tb03423.x
    [157] Kawahara C, Okada Y, Tanikawa T, et al. Severe hypercalcemia and hypernatremia associated with calcipotriol for treatment of psoriasis[J]. J Bone Mineral Metab, 2004, 22:159-162. doi:  10.1007/s00774-003-0465-z
    [158] Rademaker M, Agnew K, Andrews M, et al. Psoriasis in those planning a family, pregnant or breast-feeding. The Australasian Psoriasis Collaboration[J]. Australasian J Dermatol, 2017. doi:  10.1111/ajd.12641. [Epub ahead of print].
    [159] Gallagher JC, Smith LM, Yalamanchili V. Incidence of hypercalciuria and hypercalcemia during vitamin D and calcium Supplementation in older women[J]. Menopause, 2014, 21: 1173-1180. doi:  10.1097/GME.0000000000000270
    [160] Vogiatzi MG, Jacobson-Dickman E, DeBoer MD. Drugs, and therapeutics committee of the pediatric endocrine society. Vitamin D supplementation and risk of toxicity in pediatrics: A review of current literature[J]. J Clin Endocrinol Metab, 2014, 99: 1132-1141. doi:  10.1210/jc.2013-3655
    [161] Kara C, Gunindi F, Ustyol A, et al. Vitamin D intoxication due to an erroneously manufactured dietary supplement in seven children[J]. Pediatrics, 2014, 133: e240-e244. http://www.ncbi.nlm.nih.gov/pubmed/24298009
    [162] Hawkes CP, Schnellbacher S, Singh RJ, et al. 25-hydroxyvitamin D can interfere with a common assay for 1, 25-dihydroxyvitamin D in vitamin D intoxication[J]. J Clin Endocrinol Metab, 2015, 100: 2883-2889. doi:  10.1210/jc.2015-2206
    [163] Hathcock JN, Shao A, Vieth R, et al. Risk assessment for vitamin D[J]. Am J Clin Nutr, 2007, 85: 6-18. doi:  10.1093/ajcn/85.1.6
    [164] Tripkovic L, Lambert H, Hart K, et al. Comparison of vitamin D2 and vitamin D3 supplementation in raising serum 25-hydroxyvitamin D status: a systematic review and meta-analysis[J]. Am J ClinNutr, 2012, 95:1357-1364. doi:  10.3945/ajcn.111.031070
    [165] Wilhelm SM, Wang TS, Ruan DT, et al. The American Association of Endocrine Surgeons Guide-lines for Definitive Management of Primary Hyperparat hyroidism[J]. JAMA Surg, 2016, 151: 959-968. doi:  10.1001/jamasurg.2016.2310
    [166] Zittermann A. The biphasic effect of Vitamin D on the musculoskeletal and cardiovascular system[J]. Int J Endocrinol, 2017, 2017:3206240. doi:  10.1155/2017/3206240
    [167] Al Mheid I, Patel RS, Tangpricha V, et al. Vitamin D and cardiovascular disease: is the evidence solid?[J]. Eur Heart J, 2013, 34: 3691-3698. http://www.wanfangdata.com.cn/details/detail.do?_type=perio&id=10.1177/000992287000900705
    [168] Tebben PJ, Singh RJ, Kumar R. Vitamin D-mediated hypercalcemia: mechanisms, diagnosis, and treat-ment[J]. Endocr Rev, 2016, 37: 521-547. doi:  10.1210/er.2016-1070
    [169] Trillini M, Cortinovis M, Ruggenenti P, et al. Paricalcitol for secondary hyperparathyroidism in renal transplantation[J]. J Am Soc Nephrol, 2015, 26: 1205-1214. doi:  10.1681/ASN.2013111185
    [170] Shoback D. Hypoparathyroidism[J]. N Engl J Med, 2008, 359:391-403. doi:  10.1056/NEJMcp0803050
    [171] Stein EM, Shane E. Vitamin D in organ trans-plantation[J]. Osteoporos Int, 2011, 22: 2107-2118. doi:  10.1007/s00198-010-1523-8
    [172] Melamed ML, Thadhani RI. Vitamin D therapy in chronic kidney disease and end stage renal disease[J]. Clin J Am Soc Nephrol, 2012, 7: 358-365. doi:  10.2215/CJN.04040411
  • 加载中

Catalog

    通讯作者: 陈斌, bchen63@163.com
    • 1. 

      沈阳化工大学材料科学与工程学院 沈阳 110142

    1. 本站搜索
    2. 百度学术搜索
    3. 万方数据库搜索
    4. CNKI搜索

    Figures(2)  / Tables(2)

    Article Metrics

    Article views (782) PDF downloads(1352) Cited by()
    Proportional views
    Related

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return